Twin Health, a metabolic health technology company, has raised $53 million in new funding led by Denmark's Maj Invest to accelerate expansion of its AI-powered digital twin platform into Fortune 500 enterprises and health plans across retail, healthcare, finance, technology, and manufacturing sectors.
Revolutionary AI Digital Twin Technology
The company's breakthrough platform creates real-time, personalized metabolic models for individuals using data from biomarkers, habits, and preferences. Unlike conventional metabolic programs that rely on medications and restrictive diets, Twin Health's system combines advanced artificial intelligence with human support teams to deliver daily, tailored guidance and live coaching.
"Twin is different. We address the root causes of chronic metabolic diseases to improve and reverse diabetes," explained the company's leadership. "Members use their own biomarker data—not population averages—to create their own AI digital twin that guides them in a way that is engaging, precise, and sustainable."
Proven Clinical Outcomes
Twin Health has published peer-reviewed clinical trial results demonstrating significant outcomes for diabetes and weight management. In a randomized clinical trial involving 33 diabetic subjects, the platform achieved remarkable results after four months of use:
- Average HbA1c reduction of 3.1 from a baseline average of 8.7
- More than 90% of subjects achieving type 2 diabetes reversal with HbA1c levels below 6.5
- 92% of participants eliminated all diabetes medications, including oral antidiabetic drugs and insulin
- Average weight reduction of more than 9 kg
- Improvements in liver function scores
- No improvement observed in the control group
Performance-Based Care Model
Twin Health distinguishes itself through a results-driven approach where employers and health plans only pay when members achieve significant clinical results, such as improved A1C levels, weight loss, or reduced medication use. If milestones aren't met, no payment is required. This performance-based model has enabled the company to achieve high client retention rates and exceptional industry conversion metrics.
Addressing GLP-1 Medication Trends
As GLP-1 medication usage continues to rise, Twin Health's platform provides organizations with evidence-based strategies for responsible implementation. The system identifies eligible individuals, supports appropriate medication use when necessary, and offers personalized pathways to reduce or eliminate long-term dependence on costly drugs.
"Diabetes and obesity are among the world's biggest health challenges," said Jeppe Christianson, CEO of Maj Invest. "Twin Health represents a paradigm shift in diabetes and obesity care—one that is precise to each individual and scalable for employers and health plans."
Comprehensive Metabolic Health Approach
The Whole Body Digital Twin platform utilizes Internet of Things sensors and self-reported data within an AI-driven software framework to generate virtual copies of users' unique metabolism. The system continuously monitors health status and delivers personalized advice on nutrition, sleep, activity, and breathing through a mobile application.
Twin Health's approach recognizes metabolic health as a continuous condition rather than an episodic event, providing 24/7 guidance to meet this reality. The company envisions a future where everyone has an AI digital twin to improve their health and reduce healthcare spending, setting a new benchmark for metabolic care through the integration of cutting-edge technology with individualized human support.
